Best Healthcare Stocks To Buy In 2023
health_and_safetyExplore Stocklytics' meticulously researched selection of the Best Healthcare Stocks to Buy in 2023, presenting opportunities in a sector pivotal for innovation and growth. These picks revolve around companies driving advancements in healthcare, pharmaceuticals, biotechnology, and healthcare services. Stocklytics identifies healthcare stocks poised for growth, considering factors like innovative pipelines, market demand, and healthcare trends. Whether you're interested in biotech breakthroughs or healthcare technology, Stocklytics' selections offer opportunities to invest in companies at the forefront of revolutionizing healthcare in the coming year.
| name | Price | $ Change | % Change | arrow_downwardMarket Cap | Score language | Tags | Volume | Avg. Volume | Technicals | Dividend Y | ROI 1Y | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 MOHMolina Healthcare | $313.73 | $12.09 | arrow_drop_up4.00% | $17.26B | High Quality | 253.51K | 310.07 | Neutralremove | - | -14.17% | |||||
 UTHRUnited Therapeutics | $369.21 | -$1.58 | arrow_drop_down0.42% | $16.52B | High Quality | 50.30K | 369.08 | Neutralremove | - | 53.87% | |||||
 INCYIncyte | $72.70 | -$0.55 | arrow_drop_down0.75% | $14.10B | S&P500 | 537.18K | 72.37 | Neutralremove | - | 32.29% | |||||
 THCTenet Healthcare | $141.57 | -$0.45 | arrow_drop_down0.32% | $13.81B | - | 226.70K | 141.98 | Neutralremove | - | 95.78% | |||||
 NBIXNeurocrine Biosciences | $126.66 | $0.79 | arrow_drop_up0.62% | $12.66B | High Quality | 219.73K | 126.20 | Neutralremove | - | 8.69% | |||||
 BMRNBioMarin Pharmaceutical | $63.81 | -$1.22 | arrow_drop_down1.87% | $12.39B | High Quality | 387.01K | 64.07 | Neutralremove | - | -32.40% | |||||
SRPTSarepta Therapeutics | $126.46 | -$1.45 | arrow_drop_down1.13% | $12.22B | - | 230.97K | 126.66 | Neutralremove | - | 46.84% | |||||
GMEDGlobus Medical | $84.51 | $0.71 | arrow_drop_up0.84% | $11.42B | - | 286.88K | 84.04 | Neutralremove | - | 82.48% | |||||
 MEDPMedpace Holdings | $341.02 | -$1.10 | arrow_drop_down0.32% | $10.64B | High Quality | 55.22K | 339.22 | Neutralremove | - | 22.00% | |||||
 EXELExelixis | $35.46 | -$0.11 | arrow_drop_down0.30% | $10.16B | High Quality | 640.79K | 35.41 | Neutralremove | - | 58.09% | |||||
 DOCSDoximity | $53.75 | $0.35 | arrow_drop_up0.65% | $9.97B | High Quality | 365.76K | 53.64 | Neutralremove | - | 119.06% | |||||
 PENPenumbra | $245.91 | $1.10 | arrow_drop_up0.44% | $9.39B | - | 50.81K | 244.63 | Neutralremove | - | 7.60% | |||||
ROIVRoivant Sciences Ltd. | $12.26 | -$0.21 | arrow_drop_down1.68% | $9.12B | High Quality | 2.45M | 12.20 | Neutralremove | - | 23.39% | |||||
ITCIIntra-Cellular Therapies | $85.40 | -$0.79 | arrow_drop_down0.91% | $9.12B | - | 115.73K | 85.30 | Neutralremove | - | 38.96% | |||||
HQYHealthEquity | $102.03 | $0.45 | arrow_drop_up0.44% | $8.75B | High Quality | 216.22K | 101.70 | Neutralremove | - | 47.74% | |||||
 JAZZJazz Pharmaceuticals PLC | $122.17 | $0.69 | arrow_drop_up0.57% | $7.35B | - | 168.51K | 122.30 | Neutralremove | - | 0.59% | |||||
BLCOBausch + Lomb Corporation | $19.48 | $0.02 | arrow_drop_up0.10% | $6.87B | High Growth | 59.59K | 19.43 | Neutralremove | - | 23.16% | |||||
LNTHLantheus Holdings | $87.22 | -$2.46 | arrow_drop_down2.74% | $6.22B | High Quality | 251.65K | 87.64 | Neutralremove | - | 14.25% | |||||
HALOHalozyme Therapeutics | $48.36 | -$0.15 | arrow_drop_down0.30% | $6.20B | High Quality | 333.20K | 48.56 | Neutralremove | - | 20.57% | |||||
CORTCorcept Therapeutics | $58.51 | -$0.74 | arrow_drop_down1.25% | $6.20B | High Quality | 109.57K | 58.55 | Neutralremove | - | 122.81% |
Showing 21-40 of 206
Results per page:
About Best Healthcare Stocks To Buy In 2023
Explore Stocklytics' meticulously researched selection of the Best Healthcare Stocks to Buy in 2023, presenting opportunities in a sector pivotal for innovation and growth. These picks revolve around companies driving advancements in healthcare, pharmaceuticals, biotechnology, and healthcare services. Stocklytics identifies healthcare stocks poised for growth, considering factors like innovative pipelines, market demand, and healthcare trends. Whether you're interested in biotech breakthroughs or healthcare technology, Stocklytics' selections offer opportunities to invest in companies at the forefront of revolutionizing healthcare in the coming year.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools